SPARC files FY26 Annual Report, 21st AGM on Aug 10, 2026

Board & Shareholder Meetings View source PDF

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-9.2%1-day move

₹251.30

prior close

₹250.49

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.4-3.3-4.1-5.3-9.2-10.5-15.1-14.4-13.9—————

Up moveDown movePending

AI summary

Sun Pharma Advanced Research (SPARC) filed FY 2025-26 Annual Report and 21st AGM notice for August 10, 2026 at 4:30 PM via video conferencing. E-voting runs August 6 to 9. FY26 revenue rose to Rs 1,89,012 lakhs with PAT of Rs 1,55,320 lakhs and EPS of Rs 47.86, driven by sale of a Priority Review Voucher for USD 195 million. Board also approved preferential issue of up to 3.85 crore warrants to promoter group at Rs 155.80, about Rs 600 crores total.

Likely market impact

Routine AGM filing. FY26 shows sharp turnaround via PRV sale. Promoter warrants issue of about Rs 600 crores signals confidence.